J&J Names Top Executive to Lead China Operations
publication date: Aug 29, 2013
Johnson & Johnson has emphasized the importance of China by restructuring its China operations and putting a single high-powered executive in charge of all three of its China business segments (pharmaceuticals, medical devices/diagnostics and consumer healthcare). To show that it is serious about China, J&J selected Jesse Wu, who had been Global Head of Consumer Healthcare for the company, to oversee its China operations. Mr. Wu’s Consumer Healthcare division generated $14.4 billion of revenue for J&J last year, while China was responsible for a much smaller $2.5 billion of the company’s sales. Apparently, J&J wants to make sure its China operations are fully optimized. More details....
Stock Symbol: (NYSE: JNJ)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.